Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.03 - The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
10:50 - 11:00 | Presenter: Shun Lu | Author(s): Qiming Wang, Guojun Zhang, Xiaorong Dong, Cheng-Ta Yang, Yong Song, Gee-Chen Chang, You Lu, Hongming Pan, Chao-Hua Chiu, Zhehai Wang, Jifeng Feng, Jianying Zhou, Xingxiang Xu, Renhua Guo, Jianhua Chen, Haihua Yang, Yuan Chen, Zhuang Yu, Her-Shyong Shiah, Chin-Chou Wang, Nong Yang, Jian Fang, Ping Wang, Kai Wang, Yanping Hu, Jianxing He, Ziping Wang, Jianhua Shi, Shaoshui Chen, Ying Cheng, Wu-Chou Su, Te-Chun Hsia, Jiuwei Cui, yuping Sun, Chih-Hsin Yang
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.05 - KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC
16:00 - 16:10 | Presenter: Corey Jay Langer | Author(s): Shirish Gadgeel, Hossein Borghaei, Amita Patnaik, Steven F. Powell, Ryan D Gentzler, James Chih-Hsin Yang, Matthew A. Gubens, Lecia Sequist, Mark Awad, Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, Andrey Loboda, Julie Kobie, Jared K. Lunceford, Mark Ayers, Gregory M Lubiniecki, Bilal Piperdi, M. Catherine Pietanza, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-107 - KEYNOTE-495/KeyImPaCT: Phase 2 Biomarker-Directed Study of Pembrolizumab-Based Therapy for Non–Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Martin Gutierrez | Author(s): Matthew Hellmann, Matthew A. Gubens, Charu Aggarwal, Daniel SW Tan, Enriqueta Felip, Wei-Sen Lam, Joanne Wing Yan Chiu, Jong-Seok Lee, James Chih-Hsin Yang, Edward Garon, Andrea Basso, Hua Ma, Lawrence Fong, Alex Snyder, Jianda Yuan, Roy S. Herbst
- Abstract
Loading... -
+
P1.01-112 - Phase 3, Randomized, Double-Blind Trial of First-Line Pembrolizumab With or Without Lenvatinib in Metastatic NSCLC: LEAP-007
09:45 - 09:45 | Presenter: Tarek Mekhail | Author(s): Sang-We Kim, Kaoru Kubota, Mariana González Del Riego, Larry Wu, Ayman Samkari, Tamer M. Fouad, James Chih-Hsin Yang
- Abstract
Loading... -
+
P1.01-118 - Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study
09:45 - 09:45 | Presenter: Maximilian J. Hochmair | Author(s): Alessandro Morabito, Desiree Hao, Cheng-Ta Yang, Ross Soo, James Chih-Hsin Yang, Rasim Gucalp, Balazs Halmos, Lara Wang, Angela Märten, Tanja Cufer
- Abstract
Loading...
-
+
ES18 - Acquired Resistance to TKIs: The Rebiopsy Case and the Future Options
- 11:00 - 12:30
- 9/09/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Targeted Therapy
- Moderators:Teresa Moran, Matteo Giaj Levra
-
+
ES18.02 - When to Switch to a New TKI : Imaging Based Crtieria or Positive Liquid Biopsy?
11:20 - 11:40 | Presenter: James Chih-Hsin Yang
- Abstract
Loading...
-
+
IS14 - Symposium by PeerVoice: Paving The Way To Better Outcomes In EGFR-Mutant NSCLC: Time To Take A Step Further? (Not IASLC CME Accredited)
- 12:30 - 14:00
- 9/09/2019
- Location: Barcelona (2005)
- Type: Industry Symposia & Workshops
- Track:
-
+
OA11 - Decomplexifying Molecular Targets, Immunotherapy and Treatment Settings in the Real World
- 14:00 - 15:30
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Kumar Prabhash, Jyoti D Patel
-
+
OA11.01 - Complex EGFR Mutations in Lung Adenocarcinoma
14:00 - 14:10 | Presenter: Shang-Gin Wu | Author(s): Chong-Jen Yu, James Chih-Hsin Yang, Jin-Yuan Shih
- Abstract
Loading...
-
+
PC03 - Adjuvant Therapy for Resected NSCLC Harboring EGFR Mutation, Chemotherapy or Targeted Therapy
- 15:45 - 17:15
- 9/09/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Pro-Con Session
- Track: Targeted Therapy
- Moderators:James Chih-Hsin Yang, Elisa Gobbini
-
+
PC03.01 - PROs
15:45 - 16:05 | Presenter: Wen-Zhao Zhong
- Abstract
Loading... -
+
PC03.02 - CONs
16:05 - 16:25 | Presenter: Jyoti D Patel
- Abstract
Loading... -
+
PC03.03 - Future Strategies in Early Stage EGFR-mut NSCLC
16:25 - 16:45 | Presenter: Vassiliki A Papadimitrakopoulou
- Abstract
Loading... -
+
PC03.04 - Q&A
16:45 - 17:15
- Abstract
No abstract available for this presentation
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-02 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
10:15 - 10:15 | Presenter: Edward Garon | Author(s): Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis Paz-Ares, David R Spigel, Michael Thomas, Bijoyesh Mookerjee, Pilar Cazorla Arratia, Jason Baum, Zhu Zewen, James Chih-Hsin Yang
- Abstract
Loading... -
+
P2.01-39 - Serial Plasma ctDNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in T790M+ NSCLC
10:15 - 10:15 | Presenter: Bin-Chi Liao | Author(s): Wei-Hsun Hsu, Jih-Hsiang Lee, Ching-Yao Yang, Tzu-Hsiu Tsai, Wei-Yu Liao, Chao-Chi Ho, Chia-Chi Lin, Jin-Yuan Shih, Chong-Jen Yu, James Chih-Hsin Yang
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-20 - ATORG-003: Dacomitinib With or Without Dose Titration as First-Line Therapy for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Aaron C Tan | Author(s): Tony Mok, Dong-Wan Kim, James Chih-Hsin Yang, Chee Lee, Ross Soo, Thanyanan Reungwetwattana, Daniel SW Tan, Herbert H. Loong
- Abstract
Loading... -
+
P2.14-60 - Afatinib in EGFR Mutation-Positive NSCLC: Activity in Patients with Brain Metastases, and Impact on CNS Progression/Spread
10:15 - 10:15 | Presenter: Kenneth John O’Byrne | Author(s): James Chih-Hsin Yang, Yi-Long Wu, Vera Hirsh, Nobuyuki Yamamoto, Sanjay Popat, Akihiro Tamiya, Angela Märten, Martin Schuler
- Abstract
Loading...